(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 3.42% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Quidelortho's revenue in 2026 is $2,674,200,000.On average, 6 Wall Street analysts forecast QDEL's revenue for 2026 to be $189,542,480,228, with the lowest QDEL revenue forecast at $180,216,222,156, and the highest QDEL revenue forecast at $196,194,296,647. On average, 6 Wall Street analysts forecast QDEL's revenue for 2027 to be $195,782,844,085, with the lowest QDEL revenue forecast at $185,153,652,900, and the highest QDEL revenue forecast at $206,000,582,708.
In 2028, QDEL is forecast to generate $202,983,263,920 in revenue, with the lowest revenue forecast at $190,708,262,487 and the highest revenue forecast at $216,424,047,612.